NO984524D0 - Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer - Google Patents

Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer

Info

Publication number
NO984524D0
NO984524D0 NO984524A NO984524A NO984524D0 NO 984524 D0 NO984524 D0 NO 984524D0 NO 984524 A NO984524 A NO 984524A NO 984524 A NO984524 A NO 984524A NO 984524 D0 NO984524 D0 NO 984524D0
Authority
NO
Norway
Prior art keywords
cholesterol
uptake inhibitors
amphipathic molecules
lipid uptake
lipid
Prior art date
Application number
NO984524A
Other languages
English (en)
Other versions
NO984524L (no
Inventor
Dario Boffelli
Helmut Hauser
Original Assignee
Dario Boffelli
Helmut Hauser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606686.5A external-priority patent/GB9606686D0/en
Priority claimed from GBGB9626920.4A external-priority patent/GB9626920D0/en
Application filed by Dario Boffelli, Helmut Hauser filed Critical Dario Boffelli
Publication of NO984524D0 publication Critical patent/NO984524D0/no
Publication of NO984524L publication Critical patent/NO984524L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO984524A 1996-03-29 1998-09-28 Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer NO984524L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606686.5A GB9606686D0 (en) 1996-03-29 1996-03-29 Medical use
GBGB9626920.4A GB9626920D0 (en) 1996-12-24 1996-12-24 Medical use
PCT/IB1997/000379 WO1997036927A1 (en) 1996-03-29 1997-03-27 Amphipathic molecules as cholesterol and other lipid uptake inhibitors

Publications (2)

Publication Number Publication Date
NO984524D0 true NO984524D0 (no) 1998-09-28
NO984524L NO984524L (no) 1998-11-30

Family

ID=26309021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984524A NO984524L (no) 1996-03-29 1998-09-28 Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer

Country Status (9)

Country Link
US (1) US20010005714A1 (no)
EP (1) EP0889906A1 (no)
JP (1) JP2000509020A (no)
CN (1) CN1109047C (no)
AU (1) AU710061B2 (no)
CA (1) CA2249459A1 (no)
NO (1) NO984524L (no)
NZ (1) NZ331980A (no)
WO (1) WO1997036927A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
EP1090634A1 (en) * 1999-10-01 2001-04-11 Helmut Hauser Agents for reducing cholesterol and lipid uptake
US7250304B2 (en) 2000-03-31 2007-07-31 The Regents Of The University Of California Functional assay of high-density lipoprotein
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
AU2007237157B2 (en) * 2000-08-24 2009-04-09 The Regents Of The University Of California Peptides that ameliorate atherosclerosis
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
JPWO2002043761A1 (ja) 2000-11-28 2004-04-02 三菱ウェルファーマ株式会社 抗肥満剤及び健康食品
US6930085B2 (en) 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
CA2486127C (en) 2002-05-17 2014-03-11 Esperion Therapeutics, Inc. Method of treating dyslipidemic disorders
EP1599173B1 (en) * 2002-11-13 2017-02-22 The Uab Research Foundation Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
DE10343815A1 (de) * 2003-09-22 2005-04-14 B.R.A.H.M.S Ag Verfahren zur Diagnose von Erkrankungen unter Bestimmung von Apolipoprotein C-I, und dessen Verwendung in der Therapie von Erkrankungen
US20060205669A1 (en) * 2004-09-16 2006-09-14 The Regents Of The University Of California G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
CN101115496B (zh) 2004-12-06 2012-03-07 加州大学评议会 改善微动脉的结构和功能的方法
MX2007013430A (es) * 2005-04-29 2008-03-19 Univ California Peptidos y peptidos mimeticos para tratar patologias caracterizadas por una respuesta inflamatoria.
US20080293639A1 (en) * 2005-04-29 2008-11-27 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
WO2007000924A1 (ja) * 2005-06-28 2007-01-04 Osaka University プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法
AU2007229604A1 (en) * 2006-03-24 2007-10-04 Unilever Plc Healthy food product
EP1836906B1 (en) * 2006-03-24 2009-07-01 Unilever N.V. Healthy food product
WO2007110296A1 (en) * 2006-03-24 2007-10-04 Unilever N.V. Healthy food product
EP2049137A4 (en) 2006-08-08 2013-05-01 Univ California SALICYLANILIDES AS AMPLIFIERS OF THE ORAL RELEASE OF THERAPEUTIC PEPTIDES
AU2008296478B9 (en) 2007-08-28 2015-03-19 The Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
US8557767B2 (en) 2007-08-28 2013-10-15 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
US7985727B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Apo A-I mimetic peptides and methods of treatment
US8044021B2 (en) 2007-09-20 2011-10-25 Abbott Cardiovascular Systems Inc. Sustained release of apo A-I mimetic peptides and methods of treatment
US7985728B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US9173890B2 (en) 2007-09-20 2015-11-03 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US8101565B2 (en) * 2007-09-20 2012-01-24 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
CN107074923B (zh) 2014-07-31 2021-08-03 Uab研究基金会 Apoe模拟肽及对清除血浆胆固醇的较高效力

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007930A1 (en) * 1993-09-15 1995-03-23 Cv Therapeutics, Inc. Protein for mediating cholesterol absorption and an inhibitor thereof
US5373009A (en) * 1994-02-02 1994-12-13 American Home Products Corporation Dibenzofuranyl esters of N-heterocyclic carboxylic acids

Also Published As

Publication number Publication date
JP2000509020A (ja) 2000-07-18
EP0889906A1 (en) 1999-01-13
CN1109047C (zh) 2003-05-21
WO1997036927A1 (en) 1997-10-09
CN1216995A (zh) 1999-05-19
NO984524L (no) 1998-11-30
AU2174197A (en) 1997-10-22
AU710061B2 (en) 1999-09-09
NZ331980A (en) 2000-09-29
CA2249459A1 (en) 1997-10-09
US20010005714A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
NO984524D0 (no) Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer
FI970762A0 (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
DK0818448T3 (da) Cycloalkanopyridiner som CETP-inhibitorer
DE69738510D1 (de) Plasmaanzeigeeinrichtung in Unterrahmenmodus
DK0925303T3 (da) Phosphinsyreamider som matrixmetalloproteaseinhibitorer
NO20020197L (no) Renseapparat og fremgangsmåte som utnytter en siloksanblanding som et lösemiddel
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
AU5523098A (en) Arylsulfonamides as phospholipase a2 inhibitors
DK1037880T3 (da) Anilider som retinsyremimetika
DK0934259T3 (da) Beta-sulfonamidohydroxamsyrer som matrixmetalloproteinase- og TACE-inhibitorer
PT956294E (pt) Inibidores da trombina
ATE229318T1 (de) Entferner für keratöse komedonen
FI982291A (fi) Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi
NO991770L (no) Bµrere som inneholder et eterlipid/komplementµr formlipidkombinasjon og terapeutisk bruk derav
FI970499A (fi) Menetelmä ja aine lipidien absorption vähentämiseksi
ATE240714T1 (de) Entferner für keratöse komedonen
DE69731574D1 (de) Kompiliergerät und -verfahren
FI943441A (fi) Tris-karbamiinihapon estereitä: kolesterolin absorption ehkäisyaineita
KR950024444U (ko) 판촉용 티슈 팩
KR970000223A (ko) 콜레스테롤 생합성 저해제
DE29702396U1 (de) Montageständer für Inline-Skater
BR7400264U (pt) Painel iluminado para mensagem promocional
BR9404556A (pt) Expositor para aplicaçao geral

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application